Rongyi C - Search Results

1

In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease.

Zongfei J, Rongyi C, Xiaomeng C, Lili M, Lingying M, Xiufang K, Xiaomin D, Zhuojun Z, Huiyong C, Ying S, Lindi J. Zongfei J, et al. Among authors: rongyi c. Front Immunol. 2020 Jul 8;11:1272. doi: 10.3389/fimmu.2020.01272. eCollection 2020. Front Immunol. 2020. PMID: 32733444 Free PMC article.

2

Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study.

Zongfei J, Lingying M, Lijuan Z, Ying S, Rongyi C, Dongmei L, Xiufang K, Xiaomin D, Lili M, Huiyong C, Lindi J. Zongfei J, et al. Among authors: rongyi c. Clin Rheumatol. 2021 Jun;40(6):2293-2300. doi: 10.1007/s10067-020-05484-8. Epub 2020 Nov 5. Clin Rheumatol. 2021. PMID: 33151477

3

Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study.

Ying S, Xiaomeng C, Xiaomin D, Jiang L, Peng L, Lili M, Rongyi C, Zongfei J, Huiyong C, Lindi J. Ying S, et al. Among authors: rongyi c. Ther Adv Musculoskelet Dis. 2020 Jun 2;12:1759720X20930114. doi: 10.1177/1759720X20930114. eCollection 2020. Ther Adv Musculoskelet Dis. 2020. PMID: 32536986 Free PMC article.

4

Effect of hydroxychloroquine on angiographic progression in routine treatment of Takayasu arteritis.

Rongyi C, Zongfei J, Jiang L, Sifan W, Lingying M, Ying S, Wenshu Y, Xiaomeng C, Xiufang K, Xiaomin D, Lili M, Yanshan L, Lindi J. Rongyi C, et al. Mod Rheumatol. 2021 Nov;31(6):1135-1141. doi: 10.1080/14397595.2021.1879347. Epub 2021 Apr 15. Mod Rheumatol. 2021. PMID: 33497271

5

Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension.

Ying S, Sifan W, Yujiao W, Rongyi C, Qingrong H, Lili M, Huiyong C, Lindi J. Ying S, et al. Among authors: rongyi c. Arthritis Res Ther. 2021 Jul 21;23(1):196. doi: 10.1186/s13075-021-02579-8. Arthritis Res Ther. 2021. PMID: 34289874 Free PMC article.

6

The difference of T cell phenotypes in end stage renal disease patients under different dialysis modality.

Xiaoyan J, Rongyi C, Xuesen C, Jianzhou Z, Jun J, Xiaoqiang D, Xiaofang Y. Xiaoyan J, et al. Among authors: rongyi c. BMC Nephrol. 2019 Aug 5;20(1):301. doi: 10.1186/s12882-019-1475-y. BMC Nephrol. 2019. PMID: 31383007 Free PMC article.

7

High level of serum complement 3 is a risk factor for vascular stenosis progression in TA patients receiving tocilizumab: a prospective observational study.

Rongyi C, Xiaojuan D, Jinghua W, Lingying M, Xiaomin D, Lili M, Huiyong C, Lindi J, Ying S. Rongyi C, et al. Arthritis Res Ther. 2023 Aug 2;25(1):137. doi: 10.1186/s13075-023-03106-7. Arthritis Res Ther. 2023. PMID: 37533103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters